论文部分内容阅读
作者研究α-受体阻断剂imidalin(2-benzyl-4,5-imidazolin hydrochloride)与各种支气管扩张剂併用对38例哮喘患者的疗效。38例哮喘患者中,过敏型31例,非过敏型7例。按大岛分类法重度者9例,中度者23例,轻度者6例。在对照观察期,所有患者均用β-受体兴奋剂(异丙肾上腺素、间羟异丙肾上腺素、舒喘灵、氯喘等)和茶硷类药物2~4周,观察期间记
The authors investigated the efficacy of the combination of the 2-benzyl-4,5-imidazolin hydrochloride, an α-blocker, and various bronchodilators in 38 patients with asthma. Of the 38 asthmatic patients, 31 were allergic and 7 were non-allergic. According to the classification of the Big Island in 9 cases, moderate in 23 cases, mild in 6 cases. During the control period, all patients were treated with beta-agonists (isoproterenol, meta-isoproterenol, salbutamol, chlorpheniramine, etc.) and theophylline for 2 to 4 weeks. During the observation period